Published in Eur J Pharmacol on November 26, 1991
Structural and mechanistic analysis of two prolyl endopeptidases: role of interdomain dynamics in catalysis and specificity. Proc Natl Acad Sci U S A (2005) 1.27
Catalysis of serine oligopeptidases is controlled by a gating filter mechanism. EMBO Rep (2000) 1.08
Attacking the multi-tiered proteolytic pathology of COPD: new insights from basic and translational studies. Pharmacol Ther (2008) 0.99
Life cycle stage-resolved proteomic analysis of the excretome/secretome from Strongyloides ratti--identification of stage-specific proteases. Mol Cell Proteomics (2011) 0.94
Induced-fit mechanism for prolyl endopeptidase. J Biol Chem (2010) 0.92
Structural analysis of prolyl oligopeptidases using molecular docking and dynamics: insights into conformational changes and ligand binding. PLoS One (2011) 0.87
Substrate- and pH-dependent contribution of oxyanion binding site to the catalysis of prolyl oligopeptidase, a paradigm of the serine oligopeptidase family. Protein Sci (2000) 0.86
Pharmacokinetics in mice implanted with xenografted tumors after intravenous administration of tasidotin (ILX651) or its carboxylate metabolite. AAPS J (2007) 0.78
Slow-binding inhibitors of prolyl oligopeptidase with different functional groups at the P1 site. Biochem J (2004) 0.75
Early recognition of children with autism: a study of first birthday home videotapes. J Autism Dev Disord (1994) 4.86
Brain structural abnormalities in young children with autism spectrum disorder. Neurology (2002) 4.20
The screening and diagnosis of autistic spectrum disorders. J Autism Dev Disord (1999) 3.77
Practice parameter: screening and diagnosis of autism: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology (2000) 3.70
The simultaneous estimation of 6-deoxy-L-galactose (L-fucose), D-mannose, D-galactose, 2-acetamido-2-deoxy-D-glucose (N-acetyl-D-glucosamine) and N-acetylneuraminic acid (sialic acid) in glycopeptides and glycoproteins. Biochim Biophys Acta (1967) 2.95
The Vineland Adaptive Behavior Scales: supplementary norms for individuals with autism. J Autism Dev Disord (1998) 2.24
Topographical distribution of complex carbohydrates in the erythrocyte membrane. J Biol Chem (1974) 2.21
Alpha-B crystallin gene (CRYAB) mutation causes dominant congenital posterior polar cataract in humans. Am J Hum Genet (2001) 2.19
Support for UK biomedical research from tobacco industry. Lancet (1997) 2.17
Completeness of case ascertainment in a Scottish regional cancer registry for the year 1992. Public Health (1997) 2.01
Brief report: Recognition of autism spectrum disorder before one year of age: a retrospective study based on home videotapes. J Autism Dev Disord (2000) 1.92
The impact of gunshot wounds on an orthopaedic surgical service in an urban trauma center. J Orthop Trauma (1997) 1.87
Gray matter abnormalities in autism spectrum disorder revealed by T2 relaxation. Neurology (2006) 1.65
A lysosomal storage disorder in mice characterized by a dual deficiency of sphingomyelinase and glucocerebrosidase. Biochim Biophys Acta (1980) 1.63
Autism and the serotonin transporter: the long and short of it. Mol Psychiatry (2005) 1.62
Maternal uniparental disomy of chromosome 13 in a phenotypically normal child. J Med Genet (1994) 1.60
EEG mu rhythm and imitation impairments in individuals with autism spectrum disorder. Brain Cogn (2007) 1.56
Prototype formation in autism. Dev Psychopathol (2001) 1.53
Evidence for multiple loci from a genome scan of autism kindreds. Mol Psychiatry (2006) 1.52
High-density SNP association study and copy number variation analysis of the AUTS1 and AUTS5 loci implicate the IMMP2L-DOCK4 gene region in autism susceptibility. Mol Psychiatry (2009) 1.45
Imitation and social responsiveness in autistic children. J Abnorm Child Psychol (1984) 1.41
Investigations on the oligosaccharide units of an A myeloma globulin. Biochem J (1968) 1.39
Regional brain chemical alterations in young children with autism spectrum disorder. Neurology (2003) 1.30
Identification and characterization of voltage-sensitive calcium channels in neuronal clonal cell lines. J Neurosci (1984) 1.24
Social stimulation and joint attention in young autistic children. J Abnorm Child Psychol (1992) 1.23
Tripronuclear human oocytes: altered cleavage patterns and subsequent karyotypic analysis of embryos. Biol Reprod (1987) 1.22
Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression. Neuropharmacology (2005) 1.18
Galanin regulates the postnatal survival of a subset of basal forebrain cholinergic neurons. Proc Natl Acad Sci U S A (2000) 1.17
Caprine beta-mannosidosis. Inherited deficiency of beta-D-mannosidase. J Biol Chem (1981) 1.17
The behavioural and neurochemical profile of the putative dopamine D3 receptor agonist, (+)-PD 128907, in the rat. Neuropharmacology (1996) 1.17
Staurosporine induces programmed cell death in embryonic neurons and activation of the ceramide pathway. J Neurochem (1996) 1.17
Benefits and limitations of pathology databases to cancer registries. J Clin Pathol (1996) 1.16
Neurochemical characteristics of a novel dorsal root ganglion X neuroblastoma hybrid cell line, F-11. J Neurochem (1987) 1.14
Characterization of a cell line derived from a human oligodendroglioma. Mol Chem Neuropathol (1992) 1.13
Genetically determined hypercholesterolemia in a rhesus monkey family due to a deficiency of the LDL receptor. J Lipid Res (1988) 1.11
Anti-immunoglobulin-induced apoptosis in WEHI 231 cells involves the slow formation of ceramide from sphingomyelin and is blocked by bcl-XL. J Biol Chem (1997) 1.11
Differential solubilization of lipids along with membrane proteins by different classes of detergents. Chem Phys Lipids (1995) 1.09
Distribution of glycosphingolipids in the serum lipoproteins of normal human subjects and patients with hypo- and hyperlipidemias. J Lipid Res (1976) 1.09
Performance evaluation of the Abbott HTLV III EIA, a test for antibody to HTLV III in donor blood. Am J Clin Pathol (1986) 1.08
Glycosphingolipids in cultured human skin fibroblasts. I. Characterization and metabolism in normal fibroblasts. J Biol Chem (1972) 1.08
Effects of tachykinins on inositol phospholipid hydrolysis in slices of hamster urinary bladder. Br J Pharmacol (1987) 1.08
Delivering quantum dot-peptide bioconjugates to the cellular cytosol: escaping from the endolysosomal system. Integr Biol (Camb) (2010) 1.07
Letter: Arachidonic acid and retinal pigmentary degeneration. Lancet (1974) 1.05
Oxidized phosphatidylcholine is a marker for neuroinflammation in multiple sclerosis brain. J Neurosci Res (2007) 1.04
Ceramide mediates the apoptotic response of WEHI 231 cells to anti-immunoglobulin, corticosteroids and irradiation. Biochem Biophys Res Commun (1994) 1.04
Glycolipid and mucopolysaccharide abnormality in fibroblasts of fabry's disease. Science (1969) 1.03
For African Americans: real health-care reform or business as usual? J Natl Med Assoc (1994) 1.00
Evidence for two distinct forms of mammalian beta-mannosidase. J Biol Chem (1982) 1.00
Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor. J Pharmacol Exp Ther (1997) 0.99
Familial spastic paraparesis syndrome associated with HTLV-I infection. N Engl J Med (1990) 0.99
Gangliosides of human spinal cord: aberrant composition of cords from patients with amyotrophic lateral sclerosis. J Neurosci Res (1984) 0.97
Cholera toxin discriminates between murine T lymphocyte proliferation stimulated by activators of protein kinase C and proliferation stimulated by IL-2. Possible role for intracellular cAMP. J Immunol (1988) 0.96
Regulation of sphingomyelinases in cells of the oligodendrocyte lineage. J Neurosci Res (2004) 0.96
I-cell disease, mucolipidosis II. Pathological, histochemical, ultrastructural and biochemical observations in four cases. Z Kinderheilkd (1973) 0.96
Differential regulation of ceramide in lipid-rich microdomains (rafts): antagonistic role of palmitoyl:protein thioesterase and neutral sphingomyelinase 2. J Neurosci Res (2005) 0.95
Oligosaccharide storage in brains from patients with fucosidosis, GM1-gangliosidosis and GM2-gangliosidosis (Sandhoff's disease). J Neurochem (1976) 0.94
Hemispheric specialization and the language abilities of autistic children. Child Dev (1986) 0.94
Glycosphingolipid levels in an unusual neurovisceral storage disease characterized by lactosylceramide galactosyl hydrolase deficiency: lactosylceramidosis. J Lipid Res (1972) 0.94
Oligodendrocyte adhesion activates protein kinase C-mediated phosphorylation of myelin basic protein. Science (1986) 0.93
Evidence for lipase abnormality: high levels of free and triacylglycerol forms of unsaturated fatty acids in neuronal ceroid-lipofuscinosis tissue. Am J Med Genet (1992) 0.93
Subclassification of children with autism and pervasive developmental disorder: a questionnaire based on Wing's subgrouping scheme. J Autism Dev Disord (1993) 0.93
Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labeled by tritiated gabapentin. Epilepsy Res (1993) 0.93
Structure of the accumulating oligosaccharide in fucosidosis. J Biol Chem (1976) 0.93
Localization of [3H]gabapentin to a novel site in rat brain: autoradiographic studies. Eur J Pharmacol (1993) 0.92
Lactosyl ceramidosis: catabolic enzyme defect of glycosphingolipid metabolism. Science (1970) 0.92
Overexpression of Akt (protein kinase B) confers protection against apoptosis and prevents formation of ceramide in response to pro-apoptotic stimuli. J Neurosci Res (1999) 0.91
Acid sphingomyelinase and inhibition by phosphate ion: role of inhibition by phosphatidyl-myo-inositol 3,4,5-triphosphate in oligodendrocyte cell signaling. J Neurochem (2004) 0.91
Ceramide regulation of the tumor suppressor phosphatase PTEN in rafts isolated from neurotumor cell lines. J Neurosci Res (2005) 0.91
Opioid peptides activate phospholipase D and protein kinase C-epsilon in chicken embryo neuron cultures. Proc Natl Acad Sci U S A (1993) 0.91
Polyclonal IgM anti-GM1 ganglioside antibody in patients with motor neuron disease and variants. Ann Neurol (1990) 0.90
Discriminative stimulus properties of the putative dopamine D3 receptor agonist, (+)-PD 128907: role of presynaptic dopamine D2 autoreceptors. Neuropharmacology (1998) 0.90
Substrate specificity of human alpha-L-fucosidase. Arch Biochem Biophys (1977) 0.90
Extra embryonic/fetal karyotypic discordance during diagnostic chorionic villus sampling. Prenat Diagn (1988) 0.89
[3H]PD 140376: a novel and highly selective antagonist radioligand for the cholecystokininB/gastrin receptor in guinea pig cerebral cortex and gastric mucosa. Mol Pharmacol (1993) 0.89
Specific receptor-mediated inhibition of cyclic AMP synthesis by dopamine in a neuroblastoma X brain hybrid cell line NCB-20. J Neurochem (1984) 0.89
Maintenance of isolated oligodendrocytes in long-term culture. Brain Res (1980) 0.89
Diagnosis of glycosphingolipidoses by urinary-sediment analysis. N Engl J Med (1971) 0.89
Stroke in renal transplant recipients. Arch Neurol (1986) 0.89
Differential responses of oligodendrocytes to tumor necrosis factor and other pro-apoptotic agents: role of ceramide in apoptosis. J Neurosci Res (1999) 0.89
Shape mapping of the hippocampus in young children with autism spectrum disorder. AJNR Am J Neuroradiol (2007) 0.88
Purification and properties of two forms of human alpha-L-fucosidase. Biochim Biophys Acta (1980) 0.88
PD 176252--the first high affinity non-peptide gastrin-releasing peptide (BB2) receptor antagonist. Bioorg Med Chem Lett (1998) 0.88
Identification of novel ligands for the gabapentin binding site on the alpha2delta subunit of a calcium channel and their evaluation as anticonvulsant agents. J Med Chem (1998) 0.88
Formation mechanism of H2Ti3O7 nanotubes. Phys Rev Lett (2003) 0.88
Mutations in the TSGA14 gene in families with autism spectrum disorders. Am J Med Genet B Neuropsychiatr Genet (2011) 0.88
Induction of the serotonin1A receptor in neuronal cells during prolonged stress and degeneration. J Neurochem (1996) 0.88
Anomeric structure of ceramide digalactoside isolated from the kidney of a patient with Fabry's disease. Biochim Biophys Acta (1972) 0.88
N-acetyl-beta-hexosaminidase beta locus defect and juvenile motor neuron disease: a case study. Ann Neurol (1986) 0.88
Cholecystokinin dipeptoid antagonists: design, synthesis, and anxiolytic profile of some novel CCK-A and CCK-B selective and "mixed" CCK-A/CCK-B antagonists. J Med Chem (1993) 0.88
Lactosyl ceramidosis: normal activity for two lactosyl ceramide beta-galactosidases. Science (1975) 0.87
Does ceramide play a role in neural cell apoptosis? J Neurosci Res (2000) 0.87
Hypoxia alters iron homeostasis and induces ferritin synthesis in oligodendrocytes. J Neurochem (1995) 0.87
A sensitive spectrophotometric method for detection of L-fucose. Anal Biochem (1977) 0.87
Palmitoyl protein thioesterase 1 protects against apoptosis mediated by Ras-Akt-caspase pathway in neuroblastoma cells. J Neurochem (2000) 0.87
Regulation of glycosphingolipid metabolism in mouse neuroblastoma and glioma cell lines. Comparison of glioma (oligodendroglioma-like) with neutroblastoma cell lines. J Biol Chem (1979) 0.87
Cyclic AMP protects against staurosporine and wortmannin-induced apoptosis and opioid-enhanced apoptosis in both embryonic and immortalized (F-11kappa7) neurons. J Neurochem (1998) 0.87
Excretion of mannose-rich complex carbohydrates by a patient with alpha-mannosidase deficiency (mannosidosis). J Pediatr (1974) 0.87
Lactosylceramidosis: lactosylceramide galactosyl hydrolase deficiency and accumulation of lactosylceramide in cultured skin fibroblasts. J Pediatr (1971) 0.86
Novel nonpeptide CCK-B antagonists: design and development of quinazolinone derivatives as potent, selective, and orally active CCK-B antagonists. J Med Chem (1998) 0.86
Use of a dipeptide chemical library in the development of non-peptide tachykinin NK3 receptor selective antagonists. J Med Chem (1996) 0.86